Researchers continue to excited about the medication , a novel dual agonist showing significant outcomes in clinical trials for body reduction . It acts by impacting two hormones : GLP-1 and GIP, that , https://isaiahrtdc498214.blogdanica.com/40959671/a-new-prospect-for-size-loss